Monte Rosa Therapeutics Inc (GLUE)
6.91
+0.40
(+6.14%)
USD |
NASDAQ |
Dec 20, 16:00
6.915
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Shareholders Equity (Quarterly): 205.46M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 43.32B |
| MEI Pharma Inc | 24.88M |
| Evoke Pharma Inc | 4.387M |
| Revance Therapeutics Inc | -163.03M |
| Vera Therapeutics Inc | 289.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 315.08M |
| Total Liabilities (Quarterly) | 109.62M |
| Current Ratio | 6.033 |